retatrutide bad breath side effects: What to know The Ugly Side of Weight-Loss
Description
Refer to the cited studies in the Research Studies section above for original source data
Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United States
Right now, GLP-1 medications are not FDA-approved for use during the postpartum or breastfeeding period
[DOI] [PubMed] [Google Scholar] Godoy-Matos AF
[22] A 2018 meta-analysis indicated that the use of DPP-4 inhibitors was associated with a 58% increased risk of developing acute pancreatitis compared to placebo or no treatment
Y.MandS.SpechtS.Marfo-DebrekyeiY.BatsaL.PfarrK.et al (2006)
